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Introduction: Uptake of screening for colorectal cancer (CRC) can reduce mortality, and 
population-based screening is offered in England. To date, there is little evidence on the associa-
tion between having a long-term condition (LTC) and CRC screening uptake. The objective of 
this study was to examine the association between having an LTC and uptake of CRC screening 
in England with the guaiac fecal occult blood test, with a particular focus on common mental 
disorders.
Methods: The study was a preregistered secondary analysis of two cohorts: first, a linked 
data set between the regional Yorkshire Health Study (YHS) and the National Health Service 
National Bowel Cancer Screening Program (BCSP, years 2006–2014); second, the national 
English Longitudinal Study of Ageing (ELSA, years 2014–2015). Individuals eligible for BCSP 
screening who participated in either the YHS (7,142) or ELSA Wave 7 (4,099) were included. 
Study registration: ClinicalTrials.gov, number NCT02503969.
Results: In both the cohorts, diabetes was associated with lower uptake (YHS odds ratio [OR] 
for non-uptake 1.35, 95% CI 1.03–1.78; ELSA 1.33, 1.03–1.72) and osteoarthritis was associ-
ated with increased uptake (YHS 0.75, 0.57–0.99; ELSA 0.76, 0.62–0.93). After controlling 
for broader determinants of health, there was no evidence of significantly different uptake for 
individuals with common mental disorders.
Conclusion: Two large independent cohorts provided evidence that uptake of CRC screening 
is lower among individuals with diabetes and higher among individuals with osteoarthritis. 
Further work should compare barriers and facilitators to screening among individuals with either 
of these conditions. This study also demonstrates the benefits of data linkage for improving 
clinical decision-making.
Keywords: colorectal cancer, fecal occult blood test, population screening, uptake, depres-
sion, anxiety
Introduction
Colorectal cancer (CRC) is a common form of cancer with over 1 million diagnoses 
globally every year.1 Deaths from CRC are the second most common cause of cancer-
related mortality in a number of countries, including the UK, USA, Japan, Australia, 
Canada, and Germany,2 with a 5-year survival of <50% in the UK.3 Screening for CRC 
can reduce mortality via earlier detection and treatment. Within England, guaiac fecal 
occult blood tests (gFOBTs) are currently used to screen biennially for CRC, as part of 
the English National Health Service (NHS) National Bowel Cancer Screening  Program 
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(BCSP). Initial evidence from the BCSP suggests that the 
program is set to reduce CRC-related mortality by 16%.4
A number of studies that have examined the factors 
that affect the uptake and acceptance of screening exist.2,5,6 
 Gender,7 ethnicity,8 socioeconomic status,9 and literacy 
 levels10 have all been identified as factors. However, there has 
been little work examining the impact of having a long-term 
condition (LTC) on CRC screening uptake. Within England, 
better management of LTCs is a priority.11,12 About 30% of the 
English population have an LTC,13 and it has been estimated 
that 70% of all NHS spend is due to LTCs.13 Evidence about 
the effects of these LTCs on the uptake of CRC screening 
is required. Hence, the aim of this study was to examine the 
association between having an LTC and non-uptake of CRC 
screening, with a particular focus on common mental health 
problems such as depression and anxiety, as these are known 
to impact on self-management14 and so may affect the rates 
of uptake.
Methods
Cohorts and linkage
Two cohorts were used in this study. The first held data on 
uptake from the BCSP which had been linked to the regional 
data from the Yorkshire Health Study (YHS) to provide 
information on participants’ sociodemographics, LTCs, and 
broader health determinants. The second cohort was from the 
English Longitudinal Study of Ageing (ELSA). There is a 
growing awareness of the importance of reproducing results.15 
The use of two large independent cohorts represents an ideal 
opportunity for prospectively validating any observed asso-
ciations. The two cohorts are discussed in turn.
Linked BCSPYHS cohort
Roll-out of the BCSP in England began in July 2006; cur-
rently eligible people aged between 60 and 74 years are 
offered biennial gFOBT screening.16 Screening uptake is 
defined as the percentage of people adequately screened out 
of those invited for gFOBT screening. An adequate screen-
ing occurs if the participants receive a definitive outcome of 
either negative (normal) or positive (abnormal) gFOBT – this 
result may be based on multiple gFOBT kits. Historically, 
uptake has been about 50% for the initial screen and about 
90% for repeat screens.17 The BCSP includes information 
about participants’ age and gender. To obtain data on a 
broader range of variables, these data were linked to the YHS.
The YHS is a longitudinal observational regional health 
study, previously known as the South Yorkshire Cohort.18,19 
All the YHS data are self-reported; a copy of the  questionnaire 
used is available online.20 Data are available for 12 named 
LTCs (depression, anxiety, fatigue, pain, insomnia, diabetes, 
breathing problems, high blood pressure, heart disease, osteo-
arthritis, stroke, and cancer), along with a free-text “other” 
LTC. Cancer was not considered in this study as reporting of 
this is likely to be affected by the uptake of CRC screening. 
The YHS also includes evidence on participants’ demograph-
ics (age when completing questionnaire [which was converted 
into age at first invitation to screening], sex, and ethnicity) 
and broader determinants of health (deprivation, education, 
smoking status, alcohol consumption in the last week, and 
physical activity levels in the last week for walking, cycling, 
and physical exercise) along with data on health-related qual-
ity of life, as measured using the EQ-5D-3L,21 and health care 
use in the last 3 months.
Ethnicity categories were based on the 16 categories used 
in the 2001 UK census, along with an extra category for 
“Gypsy/traveler.” Deprivation was measured using the 2007 
index of multiple deprivation (IMD), which is an area-based 
measure ranging from 0 to 80 (higher scores indicate higher 
levels of deprivation). The EQ-5D-3L comprises five domains 
(mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression). The questionnaire asks about health on 
the day of completing the survey, and there are three possible 
responses for each domain (no problems, moderate problems, 
and extreme problems). There were four main categories of 
health care use: hospital, other healthcarers, other carers, and 
alternative therapist, along with a free-text “other.”
Because of small numbers, ethnicity was categorized as 
“White” or “Non-White,” and categories of health care use 
were reduced from 23 to 11 (accident and emergency, hospital 
day case, hospital outpatients, hospital in-patients, GP, nurse, 
physiotherapists, other healthcarers, other carers, alterna-
tive therapists, and other health care use). In addition, three 
categories were derived for smoking status (never, former, 
and current). Further details on data cleaning are available 
in the Supplementary materials.
Data from the first wave of the YHS were used, cover-
ing the time period from June 2010 to September 2013 
inclusive. Participants in the YHS are asked “May we use 
the information you provide to look at the benefit of health 
treatments?” and “May we look at your health records?” 
Those who responded “yes” to both the questions were 
deemed to be eligible for linkage to the BCSP data. Linkage 
was based on the NHS number. Data on uptake was obtained 
from the BCSP and were available for the calendar years 
2006–2014. Participants were linked if they had ever been 
invited to screening, even if this was not in the year that 
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they  completed the survey; for example, a YHS participant 
may have completed the survey early in 2010 at the age of 
55 years and been invited to screening late in 2015 (at age 
60 years). Details on how age at first invitation to screening 
was derived are provided in the Supplementary materials. All 
other data were from the YHS. Data access was de-identified.
ELSA cohort
The ELSA is a nationally representative22 longitudinal sur-
vey designed to generate evidence on aging and quality of 
life among individuals aged ≥50 years.23 There have been 
seven waves of data collection, with the first wave collected 
in 2002/2003 and the most recent in 2014/2015. Questions 
regarding the uptake of CRC screening as part of the BCSP 
were introduced in Wave 5. The data used for this study are 
from Wave 7, collected in 2014/2015 and excluding proxy 
respondents. As part of the data collection, respondents aged 
between 55 and 75 years (inclusive) were asked “Have you 
ever completed the NHS bowl cancer screening test using 
the home test kit?” For those who responded yes, the date of 
their most recent screen was also recorded.
In addition to details on CRC screening uptake, ELSA 
also records information on a number of LTCs. For this study, 
17 self-reported LTCs were used (Table 1). Also, evidence 
on participants’ demographics (age, sex, and ethnicity) and 
broader determinants of health (self-perceived social status, 
education, smoking status, alcohol consumption in the last 
week, relationship status, and frequency of sports or exer-
cise) were also used. Cross-sectional weights were used to 
account for differences in response rates. Further details on 
the derivation of the variables are available in the Supple-
mentary materials.
Statistical analyses
The protocol for the analysis of the linked BCSP–YHS dataset 
was preregistered: ClinicalTrials.gov, number NCT02503969. 
The analysis of ELSA data was designed to reflect the analysis 
of the BCSP–YHS data as closely as possible.
A descriptive analysis compared the characteristics of 
participants who participated in CRC screening with those 
who did not participate. Comparisons were tested for statisti-
cal significance, with the caveat that as no specific differences 
were hypothesized a priori, the resulting p-values should be 
interpreted with caution. Independent two-sample t-tests were 
used to compare continuous variables, Fisher’s exact test was 
used to compare binary variables, and the Kruskal–Wallis test 
was used to compare ordinal variables. Any p-value <5% was 
considered to indicate a statistically significant association. 
The descriptive analysis also included an assessment of the 
functional form of the association between continuous vari-
ables and uptake. This included both a visual assessment and 
the use of multivariable fractional polynomials.24
To examine the association between having an LTC and 
the outcome of non-uptake of CRC screening, a series of 
logistic regression models were constructed. The first model 
included only LTCs. The second model included LTCs and 
demographics, with the third (“full” model) including LTCs, 
demographics, and broader determinants of health. This was 
designed to highlight the unadjusted association between 
morbidities and screening uptake and the degree to which 
these associations are mediated by patient characteristics. 
A distinction was made between “intrinsic” demographic 
characteristics (age, gender, and ethnicity) and broader deter-
minants of health. Evidence on health-related quality of life 
and health care use were treated as descriptive variables and 
hence not included in the regression models.
Variables for which the proportion of missing data was 
<5% were imputed using single imputation. Otherwise, 
multiple imputations were performed. In addition, as part of 
the pre-registration, power analyses were performed using 
G*Power 3.1.9.25 These suggested that, with a sample size of 
7,500 respondents, there would be an 80% power to detect an 
odds ratio of ≥1.4 and a 95% power to detect an odds ratio 
of ≥1.5. With the exception of power analyses, all statistical 
analyses were performed using STATA version 14. See the 
Supplementary materials for further details.
Ethics and approval
ELSA data were obtained from the UK Data Service; no 
approvals were required. Approvals for the linked BCSP–
YHS were obtained from the YHS study team, the BCSP 
research committee, and the Public Health England Office 
for Data Release. Ethical approval was obtained from the 
National Research Ethics Service Committee Yorkshire 
and The Humber – Leeds East (15/YH/0028). Linkage was 
restricted to participants who provided written informed 
consent for their data to be re-used in secondary analyses 
(such as this study).
Review of literature
To aid in placing the results of this study in context, a scop-
ing search was performed to identify published papers that 
consider the impact of having an LTC on screening uptake, for 
any type of cancer. Studies were limited to those that involved 
organized screening and that used statistical modeling to 
provide an estimate of the impact of having an LTC on screen-
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ing uptake, adjusted for potential confounders. In order to 
identify evidence, a number of bibliographic health databases 
were searched. Free text and thesaurus terms were combined 
to maximize the sensitivity of the search. Terms for cancer 
screening and barrier or facilitator terms were combined with 
terms for comorbidity or chronic disease. No date or language 
limits were applied to the search. Full details of search terms 
and sources are available in the Supplementary materials.
Results
A total of 7,330 participants had linked-YHS–BCSP data. 
Of these, a valid age at first invitation to screening could 
not be calculated for 181 (2.47%) participants and a further 
7 (0.10%) did not have an IMD 2007 score. Data for these 
participants were dropped from subsequent analyses, result-
ing in an overall sample of 7,142.
There were 6,105 individuals in the ELSA cohort with 
valid data on screening uptake. Of those who indicated that 
they had received a screen, 38 were unable to provide the 
year of screening, and 17 reported being screened prior to 
2006 (when screening began). A further 1,535 individuals 
were aged <61 years and hence may not have been offered 
screening. In addition, a further 405 individuals did not have 
a valid survey weight, one individual had missing ethnicity 
Table 1 Key characteristics of the two samples
Characteristics Linked-YHS ELSA
Ever participated 
in screening
 (n = 6,016)
Never  
participated 
in screening
(n = 1,126)
p-value Ever participated 
in screening
(n = 3,279)
Never  
participated 
in screening
(n = 820)
p-value
$JHPHDQ6'   0.849   0.170
Female gender   <0.001   0.002
White ethnicity   0.246   0.006
'HSULYDWLRQVFRUHPHDQ6'   <0.001
6HOISHUFHLYHGVRFLDOVWDWXVPHDQ6'   <0.001
Smoking status <0.001 <0.001
Never    
Former    
Current    
'D\VGUDQNDOFRKROLQODVWZHHNPHDQ6'   0.013   <0.001
$Q\HGXFDWLRQDOTXDOLÀFDWLRQV   <0.001   <0.001
Long-term conditions
Anxiety   0.002   0.181
'HSUHVVLRQ   <0.001   0.111
'LDEHWHV   <0.001   <0.001
High blood pressure   0.384   0.190
Osteoarthritis   0.036   0.004
Stroke   <0.001   0.064
Breathing problems   0.004
Fatigue   <0.001
Heart disease   0.037
Insomnia   0.072
Pain   0.039
Other long-term condition   0.015
Abnormal heart rhythm   0.425
Asthma   0.047
Emotional problems   0.019
Heart attack   0.007
High cholesterol   0.897
Lung disease   0.081
Osteoporosis   0.935
Other kind of arthritis   0.439
Other heart disease   1.000
Other psychiatric condition   0.043
Rheumatoid arthritis   0.812
Note:'DWDDUHQXQOHVVRWKHUZLVHVSHFLÀHG
Abbreviations: ELSA, English Longitudinal Study of Ageing; YHS, Yorkshire Health Study.
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Association between having an LTC and uptake of CRC screening
data, two had missing data on frequency of sports, and eight 
had missing alcohol data. These individuals were all excluded 
from further analyses. The resulting sample size for ELSA 
was 4,099.
Key descriptive data for the two samples are provided 
in Table 1, broken down by whether or not the individual 
participated in screening. Participation rates were 84.2% for 
the linked-YHS and 80.0% for the ELSA. Full descriptive 
data for the two samples are provided in the Supplementary 
materials. Results from both the cohorts show that compared 
to those who did participate in screening, those who did 
not participate were more likely to be male, have a higher 
deprivation score (or lower self-perceived social status), 
more likely to smoke, less likely to report drinking alcohol 
in the last week, less likely to report having an educational 
qualification, and less likely to engage in physical activities. 
Those who did not participate were also less likely to be in a 
relationship, although this was only measured in the ELSA.
The prevalence of all LTCs was also higher among those 
who did not participate in screening, with the exceptions of 
osteoarthritis and the free-text “other” for the linked-YHS, 
and osteoarthritis, abnormal heart rhythm, other heart dis-
ease, and rheumatoid arthritis for the ELSA. Based on the 
linked-YHS, those who did not participate in screening 
reported a lower mean EQ-5D score and were more likely 
to use health care services in the last 3 months, with the 
exceptions of alternative therapies and the free-text “other.”
Self-report data were available in both the cohorts for the 
prevalence of six LTCs: anxiety, depression, diabetes, high 
blood pressure, osteoarthritis, and stroke. The prevalence of 
osteoarthritis in the ELSA (29.8%) is almost twice that in 
the linked-YHS (15.2%), whereas the prevalence of anxiety 
is almost half (5.8% compared with 10.4%). The prevalence 
estimates for the remaining LTCs were similar in both the 
cohorts.
Results from the series of regression models are summa-
rized in Table 2 (linked-YHS) and Table 3 (ELSA). Further 
details of the regression models are provided in the Supple-
mentary materials. From the linked-YHS LTC-only model, 
an increased odds of non-participation was associated with 
the occurrence of stroke (odds ratio 1.72), diabetes (1.57), 
depression (1.43), or breathing problems (1.22), while the 
occurrence of osteoarthritis or a free-text “other” LTC was 
associated with increased odds of participation (odds ratios 
0.71 and 0.79, respectively). These associations persisted 
after adjusting for patient demographics. After adjustment 
for broader determinants, these associations were no longer 
significant for depression and breathing problems, but they 
remained for the other LTCs. Other variables associated 
with non-participation in the full model were male gender 
(odds ratio 1.29), increasing levels of deprivation (1.01 per 
unit increase), being a current or former smoker (2.26 and 
1.27, respectively, compared to a non-smoker), low levels 
of walking or physical exercise (odds ratios 1.43–2.10), and 
no alcohol consumption in the last week (1.36). Of the 17 
LTCs in the ELSA, only diabetes and osteoarthritis had a 
significant association with screening uptake in the LTC-
only model (odds ratios 1.69 and 0.79, respectively). In the 
full model (adjusting for patient demographics and broader 
determinants), the occurrence of diabetes was associated with 
Table 2 Results from the CRC linked-YHS cohort
Variables Long-term condition-only model Demographics-adjusted model Full model
Odds 
ratio
Standard 
error
95% CI Odds 
ratio
Standard 
error
95% CI Odds 
ratio
Standard 
error
95% CI
Fatigue 1.133 0.108 ² 1.104 0.106 ² 1.057 0.122 ²
Pain 1.053 0.089 ² 1.038 0.089 ² 0.945 0.109 ²
Insomnia 1.046 0.128 ² 1.094 0.136 ² 1.126 0.152 ²
Anxiety 1.116 0.127 ² 1.132 0.130 ² 0.951 0.146 ²
'HSUHVVLRQ 1.427 0.165 ² 1.399 0.164 ² 1.100 0.146 ²
'LDEHWHV 1.568 0.160 ² 1.560 0.161 ² 1.470 0.130 ²
Breathing problems 1.218 0.119 ² 1.257 0.124 ² 1.085 0.125 ²
High blood pressure 0.932 0.069 ² 0.967 0.073 ² 1.084 0.096 ²
Heart disease 1.038 0.117 ² 1.043 0.119 ² 1.030 0.142 ²
Osteoarthritis 0.714 0.073 ² 0.744 0.077 ² 0.743 0.130 ²
Stroke 1.722 0.290 ² 1.733 0.298 ² 1.592 0.214 ²
Other 0.789 0.059 ² 0.817 0.062 ² 0.790 0.097 ²
Notes:'DWDLQEROGDUHVWDWLVWLFDOO\VLJQLÀFDQWp<7KH´IXOOPRGHOµDOVRLQFOXGHVDJHJHQGHUHWKQLFLW\HGXFDWLRQDOTXDOLÀFDWLRQVOHYHOVRISK\VLFDODFWLYLW\SK\VLFDO
H[HUFLVHZDONLQJDQGF\FOLQJVPRNLQJVWDWXVDOFRKROXVHDQGGHSULYDWLRQVFRUH7KH´'HPRJUDSKLFVDGMXVWHGPRGHOµDOVRLQFOXGHVDJHJHQGHUDQGHWKQLFLW\6HHWKH
Supplementary materialsIRU´IXOOPRGHOµUHVXOWV
Abbreviations: CRC, colorectal cancer; YHS, Yorkshire Health Study.
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increased odds of non-participation (1.33), while the occur-
rence of osteoarthritis or rheumatoid arthritis was associated 
with increased odds of participation (0.76 and 0.64, respec-
tively). Other variables associated with non-participation 
were male gender (1.32), lower levels of self-perceived social 
status (1.01 per unit decrease), being a current smoker (2.43 
compared to a non-smoker), low levels of mild or moderate 
sports or exercise (odds ratios 1.42–1.58), no alcohol con-
sumption in the last week (1.47), and not being in a relation-
ship (1.41 compared to those who are married).
The literature review identified 14 studies that assessed 
the impact of having an LTC on the uptake of CRC screen-
ing. Of these studies, nine used a count of comorbidities and 
seven examined specific LTCs (two studies used both the 
approaches within the same analysis). Seven studies consid-
ered the impact of LTCs on the uptake of CRC screening. 
Five studies used a count of comorbidities; three of these 
found that individuals with a higher comorbidity count had 
a higher uptake of CRC screening, while two studies did 
not find any effect. Two studies examined specific LTCs. 
In these studies, having an LTC could result in increased 
or decreased CRC uptake or have no effect at all depending 
on the condition. Similar results were also observed for the 
other non-CRC screening tests considered, which suggests 
that using a simple count of comorbidities may mask the role 
of individual conditions in increasing or decreasing uptake. 
Further results, including for the other types of screening 
identified, are available in the Supplementary materials.
Discussion
Results from both the cohorts were consistent in showing 
increased uptake of CRC screening among individuals with 
osteoarthritis and decreased uptake among individuals with 
diabetes. The common mental health problems of anxiety 
and depression were self-reported in both the cohorts. In the 
linked-YHS, individuals with depression (but not anxiety) 
had lower uptake, after controlling for demographic factors. 
However, this association disappeared in the full model after 
controlling for broader determinants of health. In the ELSA, 
there was no statistically significant association for any of the 
models considered. Hence, there is some evidence to suggest 
that individuals with depression have reduced levels of CRC 
screening uptake and also that this may be due to patterns 
of broader health determinants among these individuals. 
Self-reported “emotional problems” and “other psychiatric 
conditions” were also available in the ELSA. There was no 
evidence of any statistically significant association with the 
uptake of CRC screening. However, the prevalence of these 
conditions was low among the sample (2.1% and 3.1%, 
respectively). Hence, the lack of an association may have 
Table 3 Results from the ELSA cohort
Variables Long-term conditions-only model Demographics-adjusted model Full model
Odds 
ratio
Standard 
error
95% CI Odds 
ratio
Standard 
error
95% CI Odds 
ratio
Standard 
error
95% CI
High blood pressure 1.078 0.102 ² 1.075 0.103 ² 1.107 0.111 ²
High cholesterol 0.908 0.088 ² 0.934 0.091 ² 0.867 0.09 ²
Heart attack 1.422 0.278 ² 1.364 0.279 ² 1.351 0.287 ²
'LDEHWHV 1.687 0.207 ² 1.639 0.204 ² 1.349 0.177 ²
Stroke 1.366 0.286 ² 1.361 0.285 ² 1.012 0.226 ²
Abnormal heart rhythm 0.709 0.142 ² 0.685 0.141 ² 0.759 0.16 ²
Other heart disease 1.030 0.247 ² 1.061 0.259 ² 0.983 0.239 ²
Lung disease 1.220 0.242 ² 1.264 0.255 ² 0.758 0.164 ²
Asthma 1.247 0.168 ² 1.225 0.168 ² 1.225 0.177 ²
Osteoarthritis 0.788 0.075 ² 0.841 0.083 ² 0.755 0.078 ²
Rheumatoid arthritis 0.777 0.141 ² 0.792 0.146 ² 0.645 0.12 ²
Other kind of arthritis 1.071 0.237 ² 1.112 0.246 ² 1.028 0.234 ²
Osteoporosis 1.230 0.213 ² 1.35 0.24 ² 1.159 0.213 ²
'HSUHVVLRQ 0.987 0.178 ² 0.982 0.179 ² 0.755 0.144 ²
Anxiety 0.934 0.183 ² 0.95 0.187 ² 0.84 0.176 ²
Emotional problems 1.575 0.462 ² 1.459 0.434 ² 1.414 0.432 ²
Other psychiatric 
condition
1.306 0.310 ² 1.319 0.321 ² 1.202 0.31 ²
Notes:'DWDLQEROGDUHVWDWLVWLFDOO\VLJQLÀFDQWp<7KH´IXOOPRGHOµDOVRLQFOXGHVDJHJHQGHUHWKQLFLW\VHOISHUFHLYHGVRFLDOVWDWXVUHODWLRQVKLSVWDWXVVPRNLQJVWDWXV
DOFRKROXVHHGXFDWLRQDOTXDOLÀFDWLRQVDQGIUHTXHQF\RIVSRUWVRUH[HUFLVHYLJRURXVPRGHUDWHRUPLOG7KH´'HPRJUDSKLFVDGMXVWHGPRGHOµDOVRLQFOXGHVDJHJHQGHUDQG
ethnicity. See the Supplementary materialsIRU´IXOOPRGHOµUHVXOWV
Abbreviation: ELSA, English Longitudinal Study of Ageing.
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been due to a lack of power, rather than an absence of any 
effect. Indeed, the odds ratio for emotional problems in the 
full model (1.41) was greater than that for diabetes (1.35). 
Of the remaining LTCs, the occurrence of a stroke was 
associated with lower uptake in the full linked-YHS model 
(odds ratio 1.59), but not in any of the ELSA models (odds 
ratio 1.01 in the full model). The reason for these discrepant 
findings is unclear. The free-text “other” LTC recorded in the 
linked-YHS was associated with higher uptake, although it 
is difficult to draw conclusions about this association. In the 
full ELSA model, individuals with rheumatoid arthritis had 
higher observed uptake rates. This was not a named LTC 
in the linked-YHS. It is notable that two types of arthritis 
(osteoarthritis and rheumatoid arthritis) were associated with 
increased uptake, although no association was observed for 
the LTC “other kind of arthritis.” 
To the authors’ knowledge, this is the first UK-based 
study – and the largest study internationally – to assess 
the association between named LTCs and the uptake of 
population-based CRC screening. These associations were 
examined in two independent cohorts, which improved both 
the external validity of the results and the robustness of the 
findings. Both the cohorts comprised information on a rich 
variety of potential confounders, which further strengthens 
the findings presented.
The results of this study have also shown that most of the 
existing research considers a simple count of comorbidities 
and that the presence of an LTC can be associated with either 
increased or decreased uptake. Hence, use of a simple count 
may lead to misleading results.
This study created a novel linkage between the NHS 
BCSP and the YHS. This has a number of strengths; it 
allowed for analysis of a relatively large sample size, it used 
an objective definition of CRC uptake (instead of relying on 
respondents’ self-reported uptake), and it demonstrates the 
potential for linkage to enhance the possibilities for second-
ary analysis of health care data sets in order to help improve 
clinical decision-making. A particular strength of the ELSA 
cohort is that it is a nationally representative sample of those 
aged ≥50 years.
There are some limitations in the work. Rates of screen-
ing participation were over 80% for both the cohorts. This 
is higher than that has been previously reported.17 This may 
be because this study considered participation across any 
round of screening, as opposed to participation with a single 
round. For both the cohorts, the LTCs were self-reported, and 
so may not be as clinically relevant as a doctor-diagnosed 
LTC. In addition, data were not prospectively collected for 
this study. This is particularly problematical for age, as it was 
not possible to derive a precise age at screening. The results 
presented suggest that those at the start or end of the screening 
age-range are less likely to have received an adequate screen. 
This may be an artefact of the screening process if they have 
received less invitations (screening does not commence until 
the age of 60 years and the extension of the upper age limit 
from 70 to 74 years was only fully rolled out in 2015). The 
lack of an objective measure of uptake is a further limitation 
with the ELSA data. However, self-report data on FOBT 
uptake have been shown to have sensitivity and specificity.26 
As with any self-reported data, it is important to consider the 
representativeness of the respondents. The ELSA has been 
shown to be nationally representative, while the YHS has 
been shown to slightly overrepresent older White females 
from areas of low deprivation.19 There are also differences 
between the two cohorts used. The ELSA relies on self-report 
for screening uptake (average uptake 80%) while the linked-
YHS used data recorded by the NHS BCSP (average uptake 
84%). Compared to the ELSA, individuals in the linked-YHS 
were on average 4 years younger, more likely to be male, had 
lower reported qualifications, and were more likely to report 
drinking alcohol in the last week. There were also differences 
in the prevalence of some LTCs, as previously noted. How-
ever, despite this, a number of consistent themes emerged. 
Based on the results of the literature review, it has been 
found that no previous studies have examined the association 
between CRC screening uptake and having osteoarthritis, 
while the association with diabetes has only been assessed 
in one study of 2,225 individuals (prevalence of diabetes 
24%),27 which did not find an association (odds ratio for 
receiving screening 0.90, 95% CI 0.73–1.12). Other vari-
ables were considered in both this and the previous study: 
depression, stoke, and lung disease. None of these variables 
had a significant association, which supports the findings of 
this study (with the one exception of stroke in the linked-
YHS cohort, which is associated with decreased uptake). 
The study did find that individuals with hypertension were 
more likely to receive screening (odds ratio 1.37, 95% CI 
1.12–1.66). In contrast, there was no association with high 
blood pressure in either of the cohorts analyzed in this 
study. However, it is unclear if the results from this study 
are generalizable to an English setting, as it was conducted 
in 1992 among older individuals (mean age 79 years) based 
in North Carolina.
The findings of this research are important to decision-
makers as they suggest that there are potential inequalities in 
uptake based on the presence of certain LTCs. In particular, 
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higher uptake is observed among individuals with osteoar-
thritis, and lower uptake among individuals with diabetes. 
The reasons for these associations are unclear. However, the 
two data sets comprise evidence on a rich array of factors 
that may influence uptake, such as sociodemographics and 
lifestyle factors. Hence, the observed differences in uptake 
are unlikely to be due to differences in patient-mix. Further 
research could explore and compare the barriers and facili-
tators to screening uptake experienced by individuals with 
diabetes or osteoarthritis. Such work would provide opportuni-
ties for shared learning and may help to reduce the potential 
inequalities in uptake. The results of this study also provide 
evidence that there are no inequalities in uptake for individuals 
with self-reported anxiety. For individuals with depression, 
any differences in uptake may be explained by differences in 
patterns of broader determinants of health. Further work to 
detangle the causal effects of these would be useful. 
Conclusion
Two large independent cohorts both provided evidence 
that individuals with diabetes have lower uptake of CRC 
screening while individuals with osteoarthritis have higher 
uptake. There was little evidence to suggest that individuals 
with common mental health problems had different rates of 
uptake compared to the general population. Our study results 
have the potential to improve clinical decision-making by 
providing unique evidence on patient groups who are likely 
to require further interventions to improve screening uptake 
or who can provide useful evidence about the facilitators to 
high levels of uptake.
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